|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of OB/GYN, University of Florida, Gainesville, FL, USA
* To whom correspondence should be addressed. E-mail: cheginin{at}obgyn.ufl.edu.
Gonadotropin releasing hormone analogue (GnRHa) is used for medical management of endometriosis
and premature luteinizing hormone surge during controlled ovarian stimulation. Human endometrium
expresses GnRH receptors and GnRHa alters the expression of transforming growth factor beta (TGF-
)
and receptors in endometrial cells. Since the diverse biological action of GnRHa and TGF-
are mediated
in part through mitogen-activated protein kinase (MAPK) pathway, we determined whether utilization of
MAPK/ERK and transcriptional activation of immediate early genes, c-fos and c-jun, result in differential
regulation of fibronectin, known as key regulator of embryo implantation and endometriosis progression.
Using endometrial stromal cells (ESC) and endometrial epithelial cell line (HES) we demonstrated that
GnRHa and TGF-
1 in a dose-, time- and cell-dependent manner increased the level of phosphorylated
ERK1/2 (pERK1/2). GnRH antagonist, antide also increased pERK1/2 induction in ESC and HES, while
pretreatment reduced GnRHa-induced pERK2 in ESC, but not in HES. Co-treatments with GnRHa +
TGF-
1 did not have an additive or an inhibitory effect on pERK1/2 induction compared to GnRHa or
TGF-
1 action alone. TGF-
1 and GnRHa increased ERK1/2 nuclear accumulation and inversely
regulated the expression of c-fos and c-jun, and that of fibronectin in a cell specific manner. Pretreatment
with U0126, a MEK1/2 inhibitor, blocked basal, as well as GnRHa- and TGF-
1-induced pERK1/2,
however it differentially affected c-fos, c-jun, and fibronectin expression. In conclusion, the results
indicate that GnRHa and TGF-
signaling through MAPK/ERK results in differential regulation of
fibronectin expression in endometrial cells, a molecular mechanism where short- and long-term GnRHa
therapy and locally expressed TGF-
could influence embryo implantation and endometriosis implants,
respectively.
This article has been cited by other articles:
![]() |
Q. Pan, X. Luo, T. Toloubeydokhti, and N. Chegini The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression Mol. Hum. Reprod., November 1, 2007; 13(11): 797 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamiya, K. Sakakibara, E. J. Ryer, R. P. Hom, E. B. Leof, K. C. Kent, and B. Liu Phosphorylation of the Cyclic AMP Response Element Binding Protein Mediates Transforming Growth Factor {beta}-Induced Downregulation of Cyclin A in Vascular Smooth Muscle Cells Mol. Cell. Biol., May 1, 2007; 27(9): 3489 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chegini, X. Luo, Q. Pan, A. Rhoton-Vlasak, and D.F. Archer Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy Hum. Reprod., February 1, 2007; 22(2): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W.T. Cheung, P. C.K. Leung, and A. S.T. Wong Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9. Cancer Res., November 15, 2006; 66(22): 10902 - 10910. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Li, X. Luo, Q. Pan, I. Zineh, D. F. Archer, R.S. Williams, and N. Chegini Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding Hum. Reprod., October 1, 2006; 21(10): 2555 - 2563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hastings, K. S. Jackson, P. A. Mavrogianis, and A. T. Fazleabas The Estrogen Early Response Gene FOS Is Altered in a Baboon Model of Endometriosis Biol Reprod, August 1, 2006; 75(2): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |